Results 201 to 210 of about 532,969 (259)
Advanced Science, EarlyView.In the pathological state of PD induced by MPP+, the upregulated PRMT9 in dopaminergic neurons translocates into mitochondrion and interacts with DUSP26 and catalyzes its arginine methylation, leading to the ubiquitin‐proteasomal degradation of DUSP26 mediated by Trim32.
Tengfei Liu +13 more
wiley +1 more source
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy [PDF]
Frontiers in Cellular and Infection Microbiology, 2021 Federico Bertoglio +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Human Antibodies, 1991
Many fundamental advances in our understanding of the structure and function of eukaryotic genes were derived from the study of antibody genes. Examples include mRNA splicing and rearrangement to generate antibody diversity. The capacity to immortalize an individual B cell using cell fusion permitted the generation of monoclonal antibodies.
J W, Larrick, K E, Fry
openaire +2 more sources
Many fundamental advances in our understanding of the structure and function of eukaryotic genes were derived from the study of antibody genes. Examples include mRNA splicing and rearrangement to generate antibody diversity. The capacity to immortalize an individual B cell using cell fusion permitted the generation of monoclonal antibodies.
J W, Larrick, K E, Fry
openaire +2 more sources
Generation of Recombinant Antibodies
Molecular Biotechnology, 1999Recombinant antibody technology is opening new perspectives for the development of novel therapeutic and diagnostic agents. In this review we focus on advances in the generation of both genetically engineered humanized and fully human monoclonal antibodies. Methods for their production in different expression systems are also discussed.
S M, Kipriyanov, M, Little
openaire +2 more sources
Recombinant Monoclonal Antibodies
2007Recombinant antibody technology is a rapidly evolving field that enables the study and improvement of antibody properties by means of genetic engineering. Moreover, the functional expression of antibody fragments in Escherichia coli has formed the basis for antibody library generation and selection, a powerful method to produce human antibodies for ...
Mariel, Donzeau, Achim, Knappik
openaire +2 more sources
Recombinant antibody fragments
Current Opinion in Biotechnology, 1998Recombinant antibodies and their fragments now represent over 30% of all biological proteins undergoing clinical trials, which recently culminated in FDA approval for the first engineered cancer therapeutic antibody. Other successful applications include both the effective enhancement of the human immune response for cancer therapy and the reduction of
openaire +2 more sources
Recombinant Antibodies for the Generation of Antibody Arrays
2011Affinity proteomics, mainly represented by antibody microarrays, has in recent years been established as a powerful tool for high-throughput (disease) proteomics. The technology can be used to generate detailed protein expression profiles, or protein maps, of focused set of proteins in crude proteomes and potentially even high-resolution portraits of ...
Carl A K, Borrebaeck, Christer, Wingren
openaire +2 more sources
Recombinant therapeutic antibodies
Applied Microbiology and Biotechnology, 2007Recombinant antibody technology has revolutionized the development of antibody therapeutics. This minireview offers an overview of enabling technologies and future prospects of this rapidly progressing field.
openaire +2 more sources